Now available STEQEYMA®

STEQEYMA® (ustekinumab-stba) injection, for subcutaneous or intravenous use, is indicated for the treatment of moderate to severe plaque psoriasis in children and adolescent patients from the age of 6 years and older, who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies.

View full prescribing information.